5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseChronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorderRecruitingPhase 32026-09-28NCT07464587
Phase II Trial of RC1416 Injection in AsthmaModerate to Severe AsthmaRecruitingPhase 22026-09-10NCT07403487
TQC2731 Clinical Trial for the Treatment of Severe Asthma With InjectionHypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorderRecruitingPhase 32026-08-19NCT06829784
The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patientsacute coronary syndrome, cardiovascular disorder, heart disorder, myocardial ischemia, vascular disorderRecruitingPhase 42025-09-16NCT04728516
Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseChronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorderNot yet recruitingPhase 32025-09-10NCT07147946